• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nature: Systems biology of vaccination for seasonal influenza in humans

tetano

Editor, Senior Moderator
Nature Immunology | Resource
Systems biology of vaccination for seasonal influenza in humans

Helder I Nakaya,
Jens Wrammert,
Eva K Lee,
Luigi Racioppi,
Stephanie Marie-Kunze,
W Nicholas Haining,
Anthony R Means,
Sudhir P Kasturi,
Nooruddin Khan,
Gui-Mei Li,
Megan McCausland,
Vibhu Kanchan,
Kenneth E Kokko,
Shuzhao Li,
Rivka Elbein,
Aneesh K Mehta,
Alan Aderem,
Kanta Subbarao,
Rafi Ahmed
& Bali Pulendran

Affiliations
Contributions
Corresponding author

Nature Immunology
(2011)
doi:10.1038/ni.2067

Received
12 April 2011
Accepted
06 June 2011
Published online
10 July 2011



Here we have used a systems biology approach to study innate and adaptive responses to vaccination against influenza in humans during three consecutive influenza seasons. We studied healthy adults vaccinated with trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV). TIV induced higher antibody titers and more plasmablasts than LAIV did. In subjects vaccinated with TIV, early molecular signatures correlated with and could be used to accurately predict later antibody titers in two independent trials. Notably, expression of the kinase CaMKIV at day 3 was inversely correlated with later antibody titers. Vaccination of CaMKIV-deficient mice with TIV induced enhanced antigen-specific antibody titers, which demonstrated an unappreciated role for CaMKIV in the regulation of antibody responses. Thus, systems approaches can be used to predict immunogenicity and provide new mechanistic insights about vaccines.

http://www.nature.com/ni/journal/vaop/ncurrent/full/ni.2067.html
 
Back
Top Bottom